Global Metabolic Disorders Therapeutics Market Research Report 2017

August 2017 | 115 pages | ID: G3A2A4F252BEN
QYResearch

Abstracts

In this report, the global Metabolic Disorders Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Metabolic Disorders Therapeutics in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Metabolic Disorders Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Novo Nordisk
• Sanofi
• Merck
• AstraZeneca
• Eli Lily
• AbbVie
• Actelion Pharmaceuticals
• Adocia
• Aegerion Pharmaceuticals
• Akros Pharma
• Alnylam Pharmaceuticals
• Amarin
• Amicus Therapeutics
• Biopharma
• Arena Pharmaceuticals
• Astellas Pharma
• Bionaturis
• Diasome Pharmaceuticals
• Lexicon Pharmaceuticals
• Ligand Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Metachromatic Leukodystrophy
• Globoid Leukodystrophy
• Hepatic Encephalopathy
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Metabolic Disorders Therapeutics for each application, including

• Diabetes
• Obesity
• Hypercholesterolemia
• Lysosomal storage diseases

Contents

Global Metabolic Disorders Therapeutics Market Research Report 2017

1 METABOLIC DISORDERS THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Metabolic Disorders Therapeutics
1.2 Metabolic Disorders Therapeutics Segment by Type (Product Category)
  1.2.1 Global Metabolic Disorders Therapeutics Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global Metabolic Disorders Therapeutics Production Market Share by Type (Product Category) in 2016
  1.2.3 Metachromatic Leukodystrophy
  1.2.4 Globoid Leukodystrophy
  1.2.5 Hepatic Encephalopathy
  1.2.6 Others
1.3 Global Metabolic Disorders Therapeutics Segment by Application
  1.3.1 Metabolic Disorders Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Diabetes
  1.3.3 Obesity
  1.3.4 Hypercholesterolemia
  1.3.5 Lysosomal storage diseases
1.4 Global Metabolic Disorders Therapeutics Market by Region (2012-2022)
  1.4.1 Global Metabolic Disorders Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Metabolic Disorders Therapeutics (2012-2022)
  1.5.1 Global Metabolic Disorders Therapeutics Revenue Status and Outlook (2012-2022)
  1.5.2 Global Metabolic Disorders Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL METABOLIC DISORDERS THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Metabolic Disorders Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Metabolic Disorders Therapeutics Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Metabolic Disorders Therapeutics Production and Share by Manufacturers (2012-2017)
2.2 Global Metabolic Disorders Therapeutics Revenue and Share by Manufacturers (2012-2017)
2.3 Global Metabolic Disorders Therapeutics Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Metabolic Disorders Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Metabolic Disorders Therapeutics Market Competitive Situation and Trends
  2.5.1 Metabolic Disorders Therapeutics Market Concentration Rate
  2.5.2 Metabolic Disorders Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL METABOLIC DISORDERS THERAPEUTICS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Metabolic Disorders Therapeutics Capacity and Market Share by Region (2012-2017)
3.2 Global Metabolic Disorders Therapeutics Production and Market Share by Region (2012-2017)
3.3 Global Metabolic Disorders Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL METABOLIC DISORDERS THERAPEUTICS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Metabolic Disorders Therapeutics Consumption by Region (2012-2017)
4.2 North America Metabolic Disorders Therapeutics Production, Consumption, Export, Import (2012-2017)
4.3 Europe Metabolic Disorders Therapeutics Production, Consumption, Export, Import (2012-2017)
4.4 China Metabolic Disorders Therapeutics Production, Consumption, Export, Import (2012-2017)
4.5 Japan Metabolic Disorders Therapeutics Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Metabolic Disorders Therapeutics Production, Consumption, Export, Import (2012-2017)
4.7 India Metabolic Disorders Therapeutics Production, Consumption, Export, Import (2012-2017)

5 GLOBAL METABOLIC DISORDERS THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Metabolic Disorders Therapeutics Production and Market Share by Type (2012-2017)
5.2 Global Metabolic Disorders Therapeutics Revenue and Market Share by Type (2012-2017)
5.3 Global Metabolic Disorders Therapeutics Price by Type (2012-2017)
5.4 Global Metabolic Disorders Therapeutics Production Growth by Type (2012-2017)

6 GLOBAL METABOLIC DISORDERS THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6.1 Global Metabolic Disorders Therapeutics Consumption and Market Share by Application (2012-2017)
6.2 Global Metabolic Disorders Therapeutics Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL METABOLIC DISORDERS THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novo Nordisk
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Novo Nordisk Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Sanofi
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Sanofi Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Merck
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Merck Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 AstraZeneca
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 AstraZeneca Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Eli Lily
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Eli Lily Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 AbbVie
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 AbbVie Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Actelion Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Actelion Pharmaceuticals Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Adocia
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Adocia Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Aegerion Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Aegerion Pharmaceuticals Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Akros Pharma
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Metabolic Disorders Therapeutics Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Akros Pharma Metabolic Disorders Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Alnylam Pharmaceuticals
7.12 Amarin
7.13 Amicus Therapeutics
7.14 Biopharma
7.15 Arena Pharmaceuticals
7.16 Astellas Pharma
7.17 Bionaturis
7.18 Diasome Pharmaceuticals
7.19 Lexicon Pharmaceuticals
7.20 Ligand Pharmaceuticals

8 METABOLIC DISORDERS THERAPEUTICS MANUFACTURING COST ANALYSIS

8.1 Metabolic Disorders Therapeutics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Metabolic Disorders Therapeutics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Metabolic Disorders Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Metabolic Disorders Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL METABOLIC DISORDERS THERAPEUTICS MARKET FORECAST (2017-2022)

12.1 Global Metabolic Disorders Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Metabolic Disorders Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Metabolic Disorders Therapeutics Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Metabolic Disorders Therapeutics Price and Trend Forecast (2017-2022)
12.2 Global Metabolic Disorders Therapeutics Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Metabolic Disorders Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Metabolic Disorders Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Metabolic Disorders Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Metabolic Disorders Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Metabolic Disorders Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Metabolic Disorders Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Metabolic Disorders Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Metabolic Disorders Therapeutics Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Metabolic Disorders Therapeutics
Figure Global Metabolic Disorders Therapeutics Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Metabolic Disorders Therapeutics Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Metachromatic Leukodystrophy
Table Major Manufacturers of Metachromatic Leukodystrophy
Figure Product Picture of Globoid Leukodystrophy
Table Major Manufacturers of Globoid Leukodystrophy
Figure Product Picture of Hepatic Encephalopathy
Table Major Manufacturers of Hepatic Encephalopathy
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Metabolic Disorders Therapeutics Consumption (K Units) by Applications (2012-2022)
Figure Global Metabolic Disorders Therapeutics Consumption Market Share by Applications in 2016
Figure Diabetes Examples
Figure Obesity Examples
Figure Hypercholesterolemia Examples
Figure Lysosomal storage diseases Examples
Figure Global Metabolic Disorders Therapeutics Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Metabolic Disorders Therapeutics Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Metabolic Disorders Therapeutics Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Metabolic Disorders Therapeutics Major Players Product Capacity (K Units) (2012-2017)
Table Global Metabolic Disorders Therapeutics Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Metabolic Disorders Therapeutics Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Metabolic Disorders Therapeutics Capacity (K Units) of Key Manufacturers in 2016
Figure Global Metabolic Disorders Therapeutics Capacity (K Units) of Key Manufacturers in 2017
Figure Global Metabolic Disorders Therapeutics Major Players Product Production (K Units) (2012-2017)
Table Global Metabolic Disorders Therapeutics Production (K Units) of Key Manufacturers (2012-2017)
Table Global Metabolic Disorders Therapeutics Production Share by Manufacturers (2012-2017)
Figure 2016 Metabolic Disorders Therapeutics Production Share by Manufacturers
Figure 2017 Metabolic Disorders Therapeutics Production Share by Manufacturers
Figure Global Metabolic Disorders Therapeutics Major Players Product Revenue (Million USD) (2012-2017)
Table Global Metabolic Disorders Therapeutics Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Metabolic Disorders Therapeutics Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Metabolic Disorders Therapeutics Revenue Share by Manufacturers
Table 2017 Global Metabolic Disorders Therapeutics Revenue Share by Manufacturers
Table Global Market Metabolic Disorders Therapeutics Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Metabolic Disorders Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Metabolic Disorders Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Metabolic Disorders Therapeutics Product Category
Figure Metabolic Disorders Therapeutics Market Share of Top 3 Manufacturers
Figure Metabolic Disorders Therapeutics Market Share of Top 5 Manufacturers
Table Global Metabolic Disorders Therapeutics Capacity (K Units) by Region (2012-2017)
Figure Global Metabolic Disorders Therapeutics Capacity Market Share by Region (2012-2017)
Figure Global Metabolic Disorders Therapeutics Capacity Market Share by Region (2012-2017)
Figure 2016 Global Metabolic Disorders Therapeutics Capacity Market Share by Region
Table Global Metabolic Disorders Therapeutics Production by Region (2012-2017)
Figure Global Metabolic Disorders Therapeutics Production (K Units) by Region (2012-2017)
Figure Global Metabolic Disorders Therapeutics Production Market Share by Region (2012-2017)
Figure 2016 Global Metabolic Disorders Therapeutics Production Market Share by Region
Table Global Metabolic Disorders Therapeutics Revenue (Million USD) by Region (2012-2017)
Table Global Metabolic Disorders Therapeutics Revenue Market Share by Region (2012-2017)
Figure Global Metabolic Disorders Therapeutics Revenue Market Share by Region (2012-2017)
Table 2016 Global Metabolic Disorders Therapeutics Revenue Market Share by Region
Figure Global Metabolic Disorders Therapeutics Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Metabolic Disorders Therapeutics Consumption (K Units) Market by Region (2012-2017)
Table Global Metabolic Disorders Therapeutics Consumption Market Share by Region (2012-2017)
Figure Global Metabolic Disorders Therapeutics Consumption Market Share by Region (2012-2017)
Figure 2016 Global Metabolic Disorders Therapeutics Consumption (K Units) Market Share by Region
Table North America Metabolic Disorders Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Metabolic Disorders Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Metabolic Disorders Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Metabolic Disorders Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Metabolic Disorders Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Metabolic Disorders Therapeutics Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Metabolic Disorders Therapeutics Production (K Units) by Type (2012-2017)
Table Global Metabolic Disorders Therapeutics Production Share by Type (2012-2017)
Figure Production Market Share of Metabolic Disorders Therapeutics by Type (2012-2017)
Figure 2016 Production Market Share of Metabolic Disorders Therapeutics by Type
Table Global Metabolic Disorders Therapeutics Revenue (Million USD) by Type (2012-2017)
Table Global Metabolic Disorders Therapeutics Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Metabolic Disorders Therapeutics by Type (2012-2017)
Figure 2016 Revenue Market Share of Metabolic Disorders Therapeutics by Type
Table Global Metabolic Disorders Therapeutics Price (USD/Unit) by Type (2012-2017)
Figure Global Metabolic Disorders Therapeutics Production Growth by Type (2012-2017)
Table Global Metabolic Disorders Therapeutics Consumption (K Units) by Application (2012-2017)
Table Global Metabolic Disorders Therapeutics Consumption Market Share by Application (2012-2017)
Figure Global Metabolic Disorders Therapeutics Consumption Market Share by Applications (2012-2017)
Figure Global Metabolic Disorders Therapeutics Consumption Market Share by Application in 2016
Table Global Metabolic Disorders Therapeutics Consumption Growth Rate by Application (2012-2017)
Figure Global Metabolic Disorders Therapeutics Consumption Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Novo Nordisk Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Novo Nordisk Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Sanofi Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Sanofi Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Merck Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Merck Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure AstraZeneca Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure AstraZeneca Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Eli Lily Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lily Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lily Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Eli Lily Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Eli Lily Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure AbbVie Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure AbbVie Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion Pharmaceuticals Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Actelion Pharmaceuticals Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Adocia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Adocia Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Adocia Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Adocia Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Adocia Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Aegerion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aegerion Pharmaceuticals Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aegerion Pharmaceuticals Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Aegerion Pharmaceuticals Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Aegerion Pharmaceuticals Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Akros Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Akros Pharma Metabolic Disorders Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Akros Pharma Metabolic Disorders Therapeutics Production Growth Rate (2012-2017)
Figure Akros Pharma Metabolic Disorders Therapeutics Production Market Share (2012-2017)
Figure Akros Pharma Metabolic Disorders Therapeutics Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabolic Disorders Therapeutics
Figure Manufacturing Process Analysis of Metabolic Disorders Therapeutics
Figure Metabolic Disorders Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Metabolic Disorders Therapeutics Major Manufacturers in 2016
Table Major Buyers of Metabolic Disorders Therapeutics
Table Distributors/Traders List
Figure Global Metabolic Disorders Therapeutics Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Metabolic Disorders Therapeutics Price (Million USD) and Trend Forecast (2017-2022)
Table Global Metabolic Disorders Therapeutics Production (K Units) Forecast by Region (2017-2022)
Figure Global Metabolic Disorders Therapeutics Production Market Share Forecast by Region (2017-2022)
Table Global Metabolic Disorders Therapeutics Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Metabolic Disorders Therapeutics Consumption Market Share Forecast by Region (2017-2022)
Figure North America Metabolic Disorders Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Metabolic Disorders Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Metabolic Disorders Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Metabolic Disorders Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Metabolic Disorders Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Metabolic Disorders Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Metabolic Disorders Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Metabolic Disorders Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Metabolic Disorders Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Metabolic Disorders Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Metabolic Disorders Therapeutics Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Metabolic Disorders Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Metabolic Disorders Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Metabolic Disorders Therapeutics Production (K Units) Forecast by Type (2017-2022)
Figure Global Metabolic Disorders Therapeutics Production (K Units) Forecast by Type (2017-2022)
Table Global Metabolic Disorders Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Metabolic Disorders Therapeutics Revenue Market Share Forecast by Type (2017-2022)
Table Global Metabolic Disorders Therapeutics Price Forecast by Type (2017-2022)
Table Global Metabolic Disorders Therapeutics Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Metabolic Disorders Therapeutics Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source